- Home
- ADCT vs SFST Comparison
ADCT vs SFST Comparison
Compare ADCT & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SFST
- Stock Information
- Founded
- ADCT 2011
- SFST 1999
- Country
- ADCT Switzerland
- SFST United States
- Employees
- ADCT N/A
- SFST N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SFST Major Banks
- Sector
- ADCT Health Care
- SFST Finance
- Exchange
- ADCT Nasdaq
- SFST Nasdaq
- Market Cap
- ADCT 241.0M
- SFST 285.9M
- IPO Year
- ADCT 2020
- SFST 1999
- Fundamental
- Price
- ADCT $2.78
- SFST $35.69
- Analyst Decision
- ADCT Strong Buy
- SFST Buy
- Analyst Count
- ADCT 6
- SFST 1
- Target Price
- ADCT $7.80
- SFST $43.00
- AVG Volume (30 Days)
- ADCT 937.9K
- SFST 16.9K
- Earning Date
- ADCT 08-05-2025
- SFST 07-17-2025
- Dividend Yield
- ADCT N/A
- SFST N/A
- EPS Growth
- ADCT N/A
- SFST 37.29
- EPS
- ADCT N/A
- SFST 2.25
- Revenue
- ADCT $75,817,000.00
- SFST $97,501,000.00
- Revenue This Year
- ADCT $10.65
- SFST $4.07
- Revenue Next Year
- ADCT $15.05
- SFST $8.99
- P/E Ratio
- ADCT N/A
- SFST $15.81
- Revenue Growth
- ADCT 10.49
- SFST 11.95
- 52 Week Low
- ADCT $1.05
- SFST $26.43
- 52 Week High
- ADCT $4.13
- SFST $45.91
- Technical
- Relative Strength Index (RSI)
- ADCT 47.62
- SFST 51.86
- Support Level
- ADCT $3.21
- SFST $34.80
- Resistance Level
- ADCT $3.97
- SFST $37.17
- Average True Range (ATR)
- ADCT 0.38
- SFST 0.89
- MACD
- ADCT -0.12
- SFST -0.07
- Stochastic Oscillator
- ADCT 3.43
- SFST 63.53
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.